PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 71 filers reported holding PASSAGE BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,980 | -30.1% | 13,647 | 0.0% | 0.00% | – |
| Q2 2023 | $12,846 | -1.7% | 13,647 | 0.0% | 0.00% | – |
| Q1 2023 | $13,070 | -30.6% | 13,647 | 0.0% | 0.00% | – |
| Q4 2022 | $18,833 | +10.8% | 13,647 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | -61.4% | 13,647 | -27.0% | 0.00% | – |
| Q2 2022 | $44,000 | -88.9% | 18,699 | -85.4% | 0.00% | – |
| Q1 2022 | $398,000 | -51.5% | 128,397 | -0.5% | 0.00% | – |
| Q4 2021 | $820,000 | -73.7% | 129,096 | -58.8% | 0.00% | -100.0% |
| Q3 2021 | $3,117,000 | -20.1% | 313,008 | +6.3% | 0.00% | 0.0% |
| Q2 2021 | $3,899,000 | -20.6% | 294,478 | +4.8% | 0.00% | 0.0% |
| Q1 2021 | $4,913,000 | +2.2% | 281,032 | +49.6% | 0.00% | 0.0% |
| Q4 2020 | $4,805,000 | +124.7% | 187,895 | +15.3% | 0.00% | 0.0% |
| Q3 2020 | $2,138,000 | -54.6% | 163,019 | -5.3% | 0.00% | 0.0% |
| Q2 2020 | $4,707,000 | – | 172,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |